Neva Sgr. — 2026 Investments
2 investments dated 2026 · listed companies and verified rows first · show all
Nuclidium develops copper-based radioligand therapeutics and diagnostics for cancer treatment and diagnosis, with programs targeting prostate and breast cancer using Copper-61 and Copper-67 isotopes.
BiotechDeep TechHealthtechMedical DevicesBasel, CH
Leila Jaafar(CEO)Gustav(Medical Advisor)
Co-investorsAngelini VenturesDeepTech & Climate FondsKurma PartnersVIVES Partners
Straiker builds security software for enterprise AI agents, offering agent discovery, autonomous red teaming for attack paths, and runtime protection across tools, data, MCP servers, and workflows.
AI & Machine LearningCybersecurityEnterprise SoftwareMountain View, US
Ankur Shah(Founder)inSreenath Kurupati(Founder)in
Co-investorsBain Capital VenturesGTM CapitalLightspeed Venture PartnersRain CapitalCiti VenturesIlluminate Financial+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.








